Keenova Advances Podiatry Pipeline with First Patient Dosed in Phase 3 Trial of XIAFLEX® (collagenase clostridium histolyticum) for Hammer Toe
First registered, randomized Phase 3 trial evaluating the efficacy, safety, and tolerability of XIAFLEX in adults with hammer toeNo FDA-approved nonsurgical therapies currently indicated for the treatment of hammer toeHammer toe treatment today is limited to mainly orthotics,…